PIK3CA and cancer: The phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) gene is mutated and/or amplified/gained in numerous cancers, leading to dysregulation of the PI3K-AKT-mTOR pathway and resulting in increased cell proliferation, angiogenesis and survival [6].